These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma. Sekine H; Hayes DF; Ohno T; Keefe KA; Schaetzl E; Bast RC; Knapp R; Kufe DW J Clin Oncol; 1985 Oct; 3(10):1355-63. PubMed ID: 2413181 [TBL] [Abstract][Full Text] [Related]
8. An immunohistochemical study of colon-ovarian tumor antigen and colon-specific antigen in gynecologic tumors. Ueda G; Shimizu C; Saito J; Tanaka Y; Inoue M; Tanizawa O Gynecol Oncol; 1989 Oct; 35(1):90-2. PubMed ID: 2792910 [TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen in patients with gynecologic malignancies. DiSaia PJ; Haverback BJ; Dyce BJ; Morrow CP Am J Obstet Gynecol; 1975 Jan; 121(2):159-63. PubMed ID: 163585 [TBL] [Abstract][Full Text] [Related]
10. An assessment of sequential measurements of immune complex levels in ovarian cancer patients with respect to clinical progress. Mooney NA; Townsend PA; Wiltshaw E; Evans DG; Shanti-Raju K; Poulton TA Gynecol Oncol; 1983 Apr; 15(2):207-13. PubMed ID: 6299906 [TBL] [Abstract][Full Text] [Related]
11. Characterization of antigenic components from circulating immune complexes in patients with gestational trophoblastic neoplasia. Lahey SJ; Steele G; Rodrick ML; Berkowitz R; Goldstein DP; Ross DS; Ravikumar TS; Wilson RE; Byrn R; Thomas P Cancer; 1984 Mar; 53(6):1316-21. PubMed ID: 6198067 [TBL] [Abstract][Full Text] [Related]
12. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia. Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794 [TBL] [Abstract][Full Text] [Related]
13. Activity of antibodies recovered from immune complexes of ovarian cancer patients. Lutz PM; Dawson JR Cancer Immunol Immunother; 1984; 17(3):180-9. PubMed ID: 6383602 [TBL] [Abstract][Full Text] [Related]
14. [Tissue polypeptide antigen in gynecological cancer]. Saitoh S; Nakanishi A; Noda T; Yoh S; Ando Y; Moriyama I; Ichijo M Gan No Rinsho; 1985 Jan; 31(1):65-72. PubMed ID: 3981803 [TBL] [Abstract][Full Text] [Related]
15. CA 125 in gynecologic practice. Malkasian GD; Podratz KC; Stanhope CR; Ritts RE; Zurawski VR Am J Obstet Gynecol; 1986 Sep; 155(3):515-8. PubMed ID: 2428248 [TBL] [Abstract][Full Text] [Related]
16. Quantification of polyethylene glycol precipitable circulating immune complex from carcinoma of cervix patients. Das S Arch Geschwulstforsch; 1987; 57(4):283-6. PubMed ID: 3675140 [TBL] [Abstract][Full Text] [Related]
17. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases. Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386 [TBL] [Abstract][Full Text] [Related]
18. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis. Mooney NA; Hay FC; Poulton TA Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297 [TBL] [Abstract][Full Text] [Related]
19. [Sequential determination of circulating immune complexes in ovarian tumors]. Beaufort F; Auner H; Lahousen M Wien Med Wochenschr; 1986 Jul; 136(13):317-22. PubMed ID: 3765649 [TBL] [Abstract][Full Text] [Related]